МИКРОСОСУДИСТАЯ ИШЕМИЯ И САХАРНЫЙ ДИАБЕТ: РОЛЬ СТАТИНОВ

1. Meyer C., Schwaiger M. Myocardial blood flow and glucose metabolism in diabetes mellitus.//Am J Cardiol. 1997. Vol. 80 (3A). P. 94A-101A.

2. Wiernsperger N., Bouskela E. Microcirculation: a preferred target for metformin looking beyond glycaemic control.//J. Expert Opin Pharmacother. 2003. Vol. 4. P. 525-32.

3. Wiernsperger N.F., Bouskela E. Microcirculation in insulin resistance and diabetes: more than just a complication.//Diabetes Metab. 2003. Vol. 23. P. 6S77-6S87.

4. Kalliokoski K.K., Nuutila P., Laine H. et al. Myocardial perfusion and perfusion reserve in endurance-trained men.//Med. Sci Sports Exerc. 2002 Jun. Vol. 34(6). P. 948-53.

5. Kemp Н.К. Jr. Syndrome-Х revisited.//J. Am. Coll. Cardiol. 1991. Vol. 17. P. 507-8.

6. Rosenson R.S. Statin therapy: new therapy for cardiac microvascular dysfunction.//Eur. Heart J. 2003. Vol. 24. P. 1993-1994.

7. Васильева У.Ю., Скрыпник Д.И., Артамонова Ю.В. и др. Кардиальный синдром Х.//Бюллетень НЦССХ им.А.Н. Бакулева РАМН. Сердечно-сосудистые заболевания. Креативная кардиология. Новые технологии в диагностике и лечении заболеваний сердца. 2004. Т. 5, № 3. C. 134-139.

8. Cannon R.O., Epstein S.E. "Microvascular angina" as a cause of chest pain with angiographically normal coronary arteries.//Am.J. Cardiol. 1988. Vol. 61. P. 1338.

9. Panting J.R., Gatehouse P.D., Yang G.Z. et al. Abnormal subendocardial perfusion in cardiac syndrome Х detected by cardiovascular magnetic resonance imaging.//N. Engl. J. Med. 2002. Vol. 346. P. 1948-53.

10. Hsu H.B., Shiau Y.C., Kao A et al. Technetium-99m tetrofosmin myocardial perfusion singl photon emission computed tomography in syndrom X: A preliminary report.//Jap. Heart J. 2003. Vol. 44, № 2. P. 153-162.

11. L`Abbate A., Sambuceti G., Haunso S. et al. Methods for evaluating coronary microvasculature in humans.//J. Eur. Heart. 1999. Vol. 20. P. 1300-1313

12. Kern M.J. Focus for the new millennium: diffuse coronary artery disease and physiologic measurements of severity.//ACC Current J. Review. 2000. March-April. P. 13-9.

13. DiMario C., Moses J.W., Anderson T.J. et al. Randomize comparison of elective stent implantation and coronary baloon angioplasty guided by online quantitative angiograph and intracoronary Doppler.//J. Circulation. 2000. Vol. 102. P. 2930-7.

14. Serruys P.W., de Bruyne B., Carlier S. et al. Randomize -comparison of primary stenting and provisional balloon angioplasty guided by flow velocity measurement.//J. Circulation. 2000. Vol. 102. P. 2938-44.

15. Albertal M., Regar E, Van Langenhove G. et at. on behalf of the DEBATE investigators. Flow velocity and predictors of suboptimal coronary flow velocity reserve after coronary balloon angioplasty.//J. Eur. Heart. 2002. Vol. 23. P. 133-8.

16. Nishida T., Di Mario C., Kern M.J. et al. Impact of final coronary flow velocity reserve on late outcome following stent implantation.//J. Eur. Heart 2002. Vol. 23. P. 331-40.

17. Brener S.J., Topol E.J. Epicardial versus microcirculatory dissociation.//Eur. Heart J. 2002. Vol. 23. P. 274-276.

18. Dupouy P., Pelle a, aarot P et al. Physiologically guided; angioplasty in support to a provisional stenting strategy: (immediate and six-month outcome.//J Cardiovasc Interven. 2000. Vol. 49. P. 369-75.

19. Yu Y., Ohmori K., Kondo I. et al. Correlation of functional and structural alterations of the coronary arterioles during development of type II diabetes mellitus in rats.//J. Cardiovasc. Res. 2002. Vol. 56. P. 303.

20. Jaap A.J., Tooke J.E. Pathophysiology of microvascular disease in noninsulin-dependent diabetes.//J. Clin. Sci. 1995. Vol. 89. P. 3-12.

21. Baron A.D. Insulin resistance and vascular function.//J. Diabetes Complic. 2002. Vol. 16. P. 92-102.

22. Wiernsperger N. Defects in microvascular haemodynamics during prediabetes contributor or epiphenomenon?//J. Diabetologia. 2000. Vol. 43. P. 1439-48.

23. Caballero A.E., Arora S., Saouaf R., et at. Microvascular and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes.//J. Diabetes. 1999-Vol.48. P. 1856-62.

24. Irving R.J., Walker B.R., Noon J.P. et al. Microvascular correlates of blood pressure, plasma glucose, an insulin resistance in health.//J. Cardiovasc Res. 2002. Vol. 53. P. 271-6.

25. Tooke J.E. Goh K.L. Endotheliopathy precedes type 2 diabetes.//J. Diabetes Care. 1998. Vol. 21. P. 2047-9.

26. Lichtlen P.R., Bargheer K.,Wenzlaff P. Long-term prognosis of patients with anginalike chest pain and normal coronary angiographic findings.//J. Amer. Coll. Cardiol. 1995. Vol. 25, № 5. P. 1013-1018.

27. Rosenson R.S. Statin therapy: new therapy for cardiac microvascular dysfunction.//Eur. Heart J. 2003. Vol. 24. P. 1993-1994.

28. Kayikcioglu М., Payzin S., Yavuzgil О. et al. Benefits of statin treatment in cardiac syndrome-Х.//Еur. Неагt J. 2003. Vol. 24. P. 1999-2005.

29. Fabian E., Varga А. Effect of simvastatin therapy on endothelial function of hypercholesteremic patients with syndrome-Х.//Orv. Het. J. 2002. Vol. 143. P. 2067-71.

30. Lee C.H., de Feyter P., Serruys P.W. et al. Beneficial effects of fluvastatin following percutaneous coronary intervention in patients with unstable and stable angina: results from the Lescol intervention prevention study (LIPS).//Heart. 2004. Vol. 90. P. 1156-1161.

31. Walter D.H., Fichtlscherer S., Britten M.B. et a/. Initiation of tatin therapy immediately after stent implantation: profound benefit in patients with acute coronary syndromes (Abstr).//J. Circulation. 2000. P. 244.

32. Карпов Р.С., Кошельская О.А., Суслов Т.Е. и др. Журавлева О.А. Исследования клинической эффективности гиполипидемической терапии симвастатином у больных сахарным диабетом, получающих комбинированную антигипертензивную терапию.//РМЖ. 2005. № 12.